Epilepsy Market Research Reports & Industry Analysis
Epilepsy Industry Research & Market Reports
-
2024 Global Forecast for Epilepsy Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
Medical Cannabis Market Report by Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceutical Industry, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others), and Region 2024-2032
... (Oral Solutions and Capsules, Vaporizers, Topicals, and Others), and Region 2024-2032 The global medical cannabis market size reached US$ 34.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 66.7 Billion ... Read More
-
Thailand Medical Cannabis Market Report by Cultivated Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application Areas (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceuticals, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2024-2032
... of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2024-2032 The Thailand medical cannabis market size reached US$ 187.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,328.2 Million ... Read More
-
Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Lennox-Gastaut Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Neurodiagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
... center, diagnostic laboratories & imaging center, and research laboratories & academic institute markets. The global neurodiagnostics market is expected to reach an estimated $12.7 billion by 2030 with a CAGR of 7.1% from 2024 to ... Read More
-
Brain Monitoring Market by Devices (EEG, EMG, MEG, ICP, MRI, fMRI, CT) Accessories (Electrode, Sensor), Modality (Portable, Wearable), Indication (Stroke, TBI, Epilepsy, Headache, Sleep), End User (Hospital, Neurology center) - Global Forecast to 2028
... global brain monitoring market size is estimated to be USD 4.8 billion by 2028, from USD 3.5 billion in 2023, at a CAGR of 6.3%. The brain monitoring market experiences propulsion primarily due to heightened ... Read More
-
Artificial Intelligence in Neurology Operating Room Market by Offering (Services, Software), Application (Brain Mapping, Epilepsy Diagnosis, Integration & Connectivity), Indication - Global Forecast 2024-2030
... at USD 107.57 million in 2023 and expected to reach USD 140.62 million in 2024, at a CAGR 32.24% to reach USD 760.85 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Wireless Brain Sensors Market by Type of Product (Accessories, Electroencephalography (EEG) Devices, Intracranial Pressure (ICP) Monitors), Application (Dementia, Epilepsy, Huntington's Disease), End-User - Global Forecast 2024-2030
... USD 486.24 million in 2023 and expected to reach USD 545.88 million in 2024, at a CAGR 12.35% to reach USD 1,099.20 million by 2030. Global Wireless Brain Sensors Market FPNV Positioning Matrix The FPNV ... Read More
-
Deep Brain Stimulation Devices Market by Product (Dual-Channel, Single Channel), Application (Depression, Dystonia, Epilepsy), End-User - Global Forecast 2024-2030
... expected to reach USD 1.76 billion in 2024, at a CAGR 15.06% to reach USD 4.10 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Deep Brain Stimulation Devices ... Read More
-
Epilepsy Drug Market by Product Type (First-Generation Drugs, Second-Generation Drugs, Third-Generation Drugs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores) - Global Forecast 2024-2030
... and expected to reach USD 4.87 billion in 2024, at a CAGR 7.09% to reach USD 7.35 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Epilepsy Drug Market. ... Read More
-
Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2024-2030
... 5.18 billion in 2023 and expected to reach USD 5.55 billion in 2024, at a CAGR 7.90% to reach USD 8.84 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
South & Central America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The South & Central America deep brain simulation market is expected to grow from US$ 27.53 million in ... Read More
-
Middle East & Africa Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The Middle East & Africa deep brain simulation market is expected to grow from US$ 25.64 million in ... Read More
-
Stereotactic Surgery Devices Market by Device (Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam), Application (Arteriovenous Malformations Treatment, Brain Tumor Treatment, Epilepsy Treatment), End-User - Global Forecast 2024-2030
... estimated at USD 25.23 billion in 2023 and expected to reach USD 26.47 billion in 2024, at a CAGR 5.29% to reach USD 36.21 billion by 2030. Global Stereotactic Surgery Devices Market FPNV Positioning Matrix ... Read More
-
Acetazolamide Market by Dosage Form (Capsules, Injection, Tablets), Disease (Altitude Sickness, Epilepsy, Glaucoma), Distribution Channel - Global Forecast 2024-2030
... USD 299.50 million in 2024, at a CAGR 6.47% to reach USD 436.71 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Acetazolamide Market. It offers a comprehensive assessment ... Read More
-
Childhood Absence Epilepsy Treatment Market by Drug (Lamotrigine, Valproate), Disease Type (Atypical Absence Seizures, Typical Absence Seizures) - Global Forecast 2024-2030
... 2023 and expected to reach USD 255.22 million in 2024, at a CAGR 7.43% to reach USD 392.81 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Childhood Absence ... Read More
-
Global Lennox-Gastaut Syndrome Treatment Market 2024-2028
... lennox-gastaut syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Epilepsy Drug Market Research Report 2024(Status and Outlook)
... 1873.11 million in 2023 and is projected to reach USD 2036.07 million by 2029, exhibiting a CAGR of 1.40% during the forecast period. This report provides a deep insight into the global Epilepsy Drug market ... Read More
-
Global Anti Epilepsy Drugs Market Research Report 2024(Status and Outlook)
... show recurring episodes and occur due to wrong signal sent by nerve cells to the brain. Antiepileptic drugs also act as mood stabilizers and also used in the treatment of bipolar disorders or neuropathic pain. ... Read More
-
Global Epilepsy Drugs Market Research Report 2024(Status and Outlook)
... by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology. The Global Epilepsy Drugs Market Size was estimated at USD 4931.85 ... Read More
-
Global Brivaracetam (Epilepsy) Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Brivaracetam (Epilepsy) industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Brivaracetam (Epilepsy). The report also introduces players in the industry ... Read More
-
Epilepsy Therapeutic Market in APAC 2024-2028
... the epilepsy therapeutic market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Infantile Spasms Therapeutics Market 2024-2028
... infantile spasms therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Anti-Epileptic Drugs Market: Analysis By Drug Generation (First Generation Second Generation, and Third Generation), By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Providers), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... of COVID-19 and Forecast up to 2028 The global Anti-Epileptic Drugs (AEDs) market in 2022 stood at US$9.39 billion and is likely to reach US$11.47 billion by 2028. Anti-Epileptic Drugs (AEDs) represent a non-invasive imaging ... Read More
-
Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... cases of LGS are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for LGS. All of the marketed products for LGS are small molecules and are mainly receptor agonists or ion ... Read More
Research Assistance
